FDAnews Device Daily Bulletin

SpectraScience Acquires Oncoscope’s Assets

Feb. 24, 2016

San Diego, Calif.-based SpectraScience has acquired the assets of Oncosope.

Oncoscope has developed an optical imaging system that automatically detects precancerous epithelial tissues with a scattering white light. Barrett’s esophagus was Oncoscope’s first primary indication. 

“Oncoscope's focus on a diagnostic for Barrett's esophagus will shorten the development time for a commercial product to address this indication,” said Michael Oliver, president and CEO of SpectraScience. "With a solution for diagnosis of cancer in the upper GI as well as the lower GI, we will be able to more efficiently utilize our manufacturing capabilities and leverage the sales channel to gastroenterologists.” — Anisa Jibrell